06/06/2025
3:16 PM | FibroGen (Issuer)
Kauffman Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
3:17 PM | FibroGen (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:18 PM | FibroGen (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
2:27 PM | ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
| Form SCHEDULE 13G/A | |
04/25/2025
4:14 PM | FibroGen (Filer)
| Form ARS | |
04/17/2025
4:00 PM | FibroGen (Filer)
| Form PRE 14A | |
03/28/2025
4:20 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
8:00 AM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
8:00 AM | FibroGen (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:15 PM | FibroGen (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
6:01 PM | DeLucia David (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for FGEN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for FibroGen and its competitors with MarketBeat's FREE daily newsletter. |
03/07/2025
6:02 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:03 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:19 PM | FibroGen (Filer)
| Form 424B5 | |
02/24/2025
4:22 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
6:00 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:49 PM | ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
5:24 PM | FibroGen (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SCHEDULE 13G/A | |
01/10/2025
5:15 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
5:16 PM | DeLucia David (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
4:01 PM | DeLucia David (Reporting)
FibroGen (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
8:15 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
7:00 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:00 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:00 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:52 PM | ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
| Form SC 13G/A | |
11/12/2024
1:33 PM | FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
11:11 AM | FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/03/2024
3:05 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
7:00 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
7:00 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
7:00 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:05 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
4:10 PM | FibroGen (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/10/2024
11:15 PM | FibroGen (Filer)
| Form EFFECT | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
FibroGen (Subject)
| Form SC 13G/A | |
06/28/2024
4:08 PM | FibroGen (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/26/2024
7:00 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
3:30 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:30 PM | Adib Deyaa (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy FGEN Stock Free FGEN Stock Alerts